J, L., M, H., B, M., K, H., C, S., & J, M. (2013). How reliable is secondary risk stratification with stimulated thyroglobulin in patients with differentiated thyroid carcinoma? Results from a retrospective study. Nuklearmedizin. Nuclear medicine, 52(3), 88. https://doi.org/10.3413/Nukmed-0517-12-07
Chicago Style (17th ed.) CitationJ, Lemb, Hüfner M, Meller B, Homayounfar K, Sahlmann C, and Meller J. "How Reliable Is Secondary Risk Stratification with Stimulated Thyroglobulin in Patients with Differentiated Thyroid Carcinoma? Results from a Retrospective Study." Nuklearmedizin. Nuclear Medicine 52, no. 3 (2013): 88. https://doi.org/10.3413/Nukmed-0517-12-07.
MLA (9th ed.) CitationJ, Lemb, et al. "How Reliable Is Secondary Risk Stratification with Stimulated Thyroglobulin in Patients with Differentiated Thyroid Carcinoma? Results from a Retrospective Study." Nuklearmedizin. Nuclear Medicine, vol. 52, no. 3, 2013, p. 88, https://doi.org/10.3413/Nukmed-0517-12-07.
